Timolol Pregnancy and Breastfeeding Warnings
Brand names: Blocadren
Medically reviewed by Drugs.com. Last updated on Jan 15, 2024.
Timolol Pregnancy Warnings
UK: Use is contraindicated.
US: This drug should be used during pregnancy only if the benefit outweighs the risk.
US FDA pregnancy category: C
This drug was not shown to be teratogenic in animals at doses approximately 40 times the maximum recommended daily human dose. Doses approximately 830 times the maximum recommended daily human dose were maternotoxic in animals and resulted in an increased number of fetal resorptions. There are no adequate and well controlled studies in pregnant women. It is not known whether this drug can cause fetal harm or adversely affect reproductive capacity in humans.
Timolol Breastfeeding Warnings
Because of the variability in excretion of this drug into breastmilk and minimal reported experience during breastfeeding, other agents may be preferred, especially while nursing a newborn or preterm infant.
A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother.
Excreted into human milk: Yes
See also
References for pregnancy information
- Cerner Multum, Inc. UK Summary of Product Characteristics.
- Cerner Multum, Inc. Australian Product Information.
- Product Information. Timolol Maleate (timolol). Mylan Pharmaceuticals Inc. 2016.
References for breastfeeding information
- Cerner Multum, Inc. UK Summary of Product Characteristics.
- Cerner Multum, Inc. Australian Product Information.
- United States National Library of Medicine. Toxnet. Toxicology Data Network. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT 2013.
- Product Information. Timolol Maleate (timolol). Mylan Pharmaceuticals Inc. 2016.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
